GOCL Corporation LtdQ2 FY18

GOCL Corporation Ltd Q2 FY18 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹308.4P/E: 5.7Market Cap: ₹1.5K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3
- GOCL Corporation is on a positive growth path in its core explosives and energetics business. - New products developed have been well accepted and exports are expanding with new countries added. - Current order book stands at approximately Rs.700 Crores including Coal India and other large customers. - Licensed capacity is expected to increase by about 42-46%, supporting volume growth. - The domestic commercial explosives industry is projected to grow at 10-12%, with GOCL targeting a higher compounded growth of 18-20% over the next three years. - GOCL projects a 20% compounded growth in commercial explosive revenues over three years, outpacing the industry. - Demand drivers include growth in coal output (expected 13-15%), mining, road infrastructure, and housing. - Capex plans are underway but being calibrated carefully due to market shifts; around Rs.30 Crores capex expected by year-end. Overall, management is confident of sustained growth driven by R&D, quality, and technical services.

See what GOCL Corporation Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • As per the discussion on pages 5 and 10, the company has not taken any new term loans recently, indicating no immediate new debt fundraising.
  • The capex plan for the current year is progressing well with about Rs.30 Crores expected to be spent by year-end, funded through existing cash resources.
  • There is no explicit mention of planned new equity fundraising in the provided transcript.
  • The company is cautious about committing to large capex due to market shifts and intends to clarify future capex plans by May.
  • Overall, no concrete plans for fresh debt or equity fundraising have been announced at this time; reliance appears to be on internal accruals and prudent capex management.

See what GOCL Corporation Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company plans to undertake capex but is cautious due to a market shift, wanting to understand it well before committing to large investments.
  • Licensed capacities are expected to increase by about 42%, which will require capex; exact figures for the next 2-3 years are yet to be finalized.
  • This year’s capex is progressing on schedule, with about Rs.30 Crores expected to be spent by year-end.
  • Competitors are announcing capex of Rs.200-300 Crores over the next 2-3 years; GOCL plans to keep pace by utilizing existing capacities and planned expansions primarily at Hyderabad and Rourkela.
  • There is a focus on modernization and expansion of existing capacity and exploring new locations.
  • On the Realty side, active marketing and development efforts are ongoing, with approvals expected and work likely to start soon (e.g., Hyderabad development expected to break ground by March).
  • No loans have been taken recently; the company maintains a good cash position for funding capex.

Track GOCL Corporation Ltd — get its next earnings analysis in your feed

How does GOCL Corporation Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisGOCL Corporation Ltd
Rev 3Mar 3

How does GOCL Corporation Ltd rank in Chemicals & Petrochemicals?

Compare GOCL Corporation Ltd against every Chemicals & Petrochemicals company (Q2 FY18) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Neogen Chemicals Ltd (Q2 FY27)

    Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how

  • Mahickra Chemicals Ltd (Q2 FY27)

    682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Vishnu Chemicals Ltd (Q2 FY27)

    2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Yasons Chemex (Q2 FY27)

    4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →